Article Text

Download PDFPDF
Nebulised lidocaine before nasogastric tube insertion reduced patient discomfort but increased risk of nasal bleeding

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

OpenUrlCrossRefPubMedWeb of Science

Q Does administration of nebulised lidocaine (lignocaine) before nasogastric tube (NGT) insertion reduce patient discomfort?


Embedded ImageDesign:

randomised, placebo controlled trial.

Embedded ImageAllocation:


Embedded ImageBlinding:

blinded {patients, clinicians, data collectors, outcome assessors, data analysts, and manuscript writers}*.

Embedded ImageFollow up period:

after NGT was secured.

Embedded ImageSetting:

emergency departments (EDs) of 2 large university hospitals in Australia.

Embedded ImagePatients:

50 patients >18 years of age (50% men) who required a NGT as part of their ED treatment. Exclusion criteria were inability to assess pain (altered mental state, language barrier, or dementia), systolic blood pressure <100 mm Hg, emergency indication for NGT insertion (eg, major trauma), allergy to lidocaine, concurrent administration of intravenous …

View Full Text


  • * Information provided by author.

  • For correspondence: Dr L Cullen, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia.

  • Source of funding: no external funding.